More Retirees Heading Back to Work: 4 Things to Consider Before You Un-Retire While it makes sense why you might want to head back to work, there are several important issues to work through.
Airbnb vs. PepsiCo: Which Stock Is a Better Buy in 2026? Airbnb's 20% net margin and minimal debt contrast sharply with PepsiCo's 8.8% margin and 2.4x leverage, but valuation premiums tell a different story.
3 Vanguard ETFs Built to Deliver Steady Long-Term Growth Vanguard has plenty of great ETFs for investors seeking long-term growth, and these three are some of the best.
Airbnb vs. Roblox: Which Stock Is a Better Buy in 2026? One is a profitable travel platform generating substantial cash. The other is a high-growth gaming company still burning through it. Their financial profiles could not be more different.
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript Royalty receipts surged 14% as guidance raised for second consecutive quarter.
United Therapeutics (UTHR) Q2 2026 Earnings Call Transcript CEO Rothblatt calls H1 2026 "one of the most consequential periods" in company history.
SharkNinja (SN) Q2 2026 Earnings Call Transcript Net sales hit $1.77 billion with 22.2% growth across all categories.
Recursion (RXRX) Q2 2026 Earnings Call Transcript AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.
CDW (CDW) Q2 2026 Earnings Call Transcript Net sales hit $6.6 billion, a record, as AI and infrastructure demand drive growth.
Perrigo (PRGO) Q2 2026 Earnings Call Transcript Market share gains offset sales decline as Perrigo completes Dermacosmetics divestiture.
3 Reasons to Buy Joby Aviation Stock Like There's No Tomorrow The leading eVTOL company is making solid progress with its transportation-as-a-service business model.
Airbnb vs. Opendoor Technologies: Which Stock Is a Better Buy in 2026? One operates a profitable global marketplace with a 20% net margin; the other posted a $1.3 billion loss last year.
Hims & Hers’ Revenue Beat Came With a Profitability Problem Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and faces an FTC lawsuit, leaving Wall Street cautious with a Hold rating.
Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million Ian Clark exercised stock options at $50.57 and immediately liquidated the position as the precision oncology company trades near $160 per share.
Fervo Energy Shares Rise as Investors Weigh Earnings Miss Against Cape Station Progress Fervo Energy Earnings missed Q2 estimates as Cape Station advanced, backlog reached $7.2 billion and the 2030 target increased.
Coinbase, Polymarket, Kalshi Face NYC Prediction Market Investigation Coinbase is swept into a New York City prediction-market probe as the CFTC pushes back against New York’s crackdown and orders Kalshi to keep operating.
Here’s How Much You Would Have Made Owning Shell Stock In The Last 5 Years Shell (
NYSE:SHEL ) has outperformed the market over the past 5 years by 6.08% on an annualized basis producing an average annual return of 17.79%. Currently, Shell has a market capitalization of $247.98 billion. Buying
Supermicro Soars On Report. Why Nvidia Is Also Rallying. Super Micro Computer's upbeat second-quarter earnings report provided a positive read-through for partner Nvidia. Supermicro stock rose.
This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Top analysts upgraded IDEX and Entegris, raised price targets. Intuitive Surgical upgraded with $500 target.
